Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 11,952 shares at $100.02 ($1.2M) on 2019-06-17, disclosed to the SEC on 2019-06-19.
Open-market sale of $1.2M BPMC by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.44 | 2,370 | $224K | 19.4% |
| 2 | $95.53 | 2,549 | $244K | 21.1% |
| 3 | $96.35 | 2,977 | $287K | 24.9% |
| 4 | $97.39 | 2,123 | $207K | 17.9% |
| 5 | $98.63 | 1,000 | $99K | 8.6% |
| 6 | $100.02 | 933 |
| $93K |
| 8.1% |
| Total | $96.46 avg | 11,952 | $1.2M | 100% |
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |